Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  hydrocortisone sodium succinate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-16 of 16 for your search:
Start Over
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: LAL-Ph-2000, NCT00526305
LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 and under
Sponsor: Other
Protocol IDs: LAL-AR-N-2005, NCT00526409
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 0 to 21
Sponsor: NCI, Other
Protocol IDs: 9404, U10CA030969, POG-9404, CDR0000064664, NCT01230983
IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 2005-0366, NCI-2012-01475, CA55164, NCT00469144
Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Gastric Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8120
Phase II Combination and Sequential Chemotherapy for Undifferentiated and Lymphoblastic Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-IM-8101
Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8118
Phase II Chemotherapy with Bisantrene Hydrochloride for Advanced Hepatoma in Relapse
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8119
Phase II Pilot Chemotherapy with Bisantrene Hydrochloride in Adults with Refractory Acute Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: SWOG-8161
Phase II Pilot Multi-Agent Chemotherapy with Adjuvant TBI in Patients with Group IV Rhabdomyosarcoma or Extraosseous Ewing's Tumor
Phase: Phase II
Type: Treatment
Status: Closed
Age: 2 to 18
Sponsor: NCI
Protocol IDs: POG-8157
ALL Adult Consortium Trial: Adult ALL Trial
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 50
Sponsor: Other
Protocol IDs: 06-254, NCT00476190
Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 200916901, UCDCC#218, NCT00895310
Start Over